April 2021 Issue
Here we share some of the strategies guiding nuclear cardiology teams in 2021.
A Test for the Masses: Understanding the Advantages of SPECT MPI and How Labs Can Make the Most of ItAn interview with Saurabh Malhotra, MD, MPH, FASNC, Director of Advanced Cardiac Imaging at Cook County Health in Chicago, Illinois
As financial pressures facing healthcare continue to grow due to the COVID-19 pandemic, it is important that nuclear cardiology teams understand the value of the tools they currently have in place, such as the widely available single-photon emission computerized tomography (SPECT) myocardial perfusion imaging (MPI) technology, and how best to optimize it. There are various ways in which a nuclear cardiology lab can enhance the technology at hand by implementing novel imaging protocols and with hardware or software upgrades.
With 2020 in the rear-view mirror, ASNC member surveys suggest that nuclear cardiology laboratories are on the road back to normal. Still, members expect there will be detours and slow-downs as their labs, hospitals, and health systems work through the longer-term ramifications of COVID-19.
In conversations about how to maintain forward motion, ASNC leaders explained the key concepts guiding their decision-making.
Thank you to our Imaging Insights editors:
Mouaz Al-Mallah, MD, MSc, FASNC
Stephen Bloom, MD, FASNC
Jamieson Bourque, MD, MS, FASNC